Chemoinformaics analysis of 5,8,11,14- Eicosatetraenoic acid
| Molecular Weight | 318.501 | nRot | 14 |
| Heavy Atom Molecular Weight | 284.229 | nRig | 5 |
| Exact Molecular Weight | 318.256 | nRing | 0 |
| Solubility: LogS | -6.316 | nHRing | 0 |
| Solubility: LogP | 6.766 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 57 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 59.345 |
| nHD | 0 | BPOL | 36.713 |
| QED | 0.213 |
| Synth | 2.772 |
| Natural Product Likeliness | 0.92 |
| NR-PPAR-gamma | 0.664 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.012 |
| HIA | 0.007 |
| CACO-2 | -4.493 |
| MDCK | 0.0000274 |
| BBB | 0.349 |
| PPB | 0.940892 |
| VDSS | 1.734 |
| FU | 0.0270534 |
| CYP1A2-inh | 0.972 |
| CYP1A2-sub | 0.143 |
| CYP2c19-inh | 0.664 |
| CYP2c19-sub | 0.061 |
| CYP2c9-inh | 0.884 |
| CYP2c9-sub | 0.934 |
| CYP2d6-inh | 0.175 |
| CYP2d6-sub | 0.164 |
| CYP3a4-inh | 0.763 |
| CYP3a4-sub | 0.07 |
| CL | 10.344 |
| T12 | 0.394 |
| hERG | 0.007 |
| Ames | 0.382 |
| ROA | 0.002 |
| SkinSen | 0.985 |
| Carcinogencity | 0.473 |
| EI | 0.94 |
| Respiratory | 0.806 |
| NR-Aromatase | 0.399 |
| Antiviral | No |
| Prediction | 0.574194 |